March 7, 2026 - 05:22

U.S. stock markets fell on Friday, capping a volatile week of losses as escalating tensions in the Middle East sent oil prices surging and rattled investor sentiment. The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all closed in negative territory.
The primary catalyst for the market's retreat was a sharp spike in global oil prices, with Brent crude breaching the $90 per barrel mark. This surge, driven by heightened geopolitical risks, stoked fears of persistent inflation and potentially higher interest rates for longer. These concerns overshadowed corporate earnings season, which is set to begin in earnest next week.
Throughout the week, equities struggled for direction as investors weighed strong economic data against the uncertain outlook for monetary policy. The jump in energy prices compounded existing anxieties, leading to broad-based selling pressure. The week's performance highlighted the market's acute sensitivity to international conflicts and their potential to disrupt energy supplies and amplify inflationary pressures, forcing a cautious retreat from risk assets.
March 6, 2026 - 07:28
Assessing Raymond James Financial (RJF) Valuation After Recent Share Price MomentumWith no single headline event driving attention to Raymond James Financial (RJF) today, the focus for investors is squarely on how its recent share performance and financial profile align with its...
March 5, 2026 - 22:07
Doman Building Materials Group Ltd. Reports 2025 Financial ResultsDoman Building Materials Group Ltd. has released its financial results for the full year and fourth quarter ending March 31, 2025, reporting solid revenue and profitability. For the full 2025...
March 5, 2026 - 02:47
Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial ResultsCross Country Healthcare has unveiled its financial performance for the final quarter and the entirety of the 2025 fiscal year, showcasing the company`s position in the healthcare staffing sector....
March 4, 2026 - 01:18
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 OutlookNeuroPace, Inc., a leader in developing responsive neurostimulation for epilepsy, has announced its financial results for the fourth quarter and full year ending December 31, 2025. The company also...